ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer

被引：0

作者：

Kamath, Suneel

Tai, David

Moreno, Irene

Babiker, Hani

Jin, Zhaohui

Yoo, Changhoon

Ricard, Fabien

Jen, Kai Yu

Coward, Jim

Liu, Jia

Opdam, Frans

Millward, Michael

Ponz-Sarvise, Mariano

Yachnin, Jeffrey

Kim, Richard

Park, Joon Oh

Subbiah, Vivek

Schram, Alison M.

机构：

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS22-OT3-24-01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OT3-24-01

引用

页数：3